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Isolation and Characterisation of a Halotolerant ω-Transaminase from a Triassic Period Salt 
Mine and Its Application to Biocatalysis 
 
Stephen A. Kelly[a], Julianne Megaw[a],  Jill Caswell[b], Christopher J. Scott[c], Christopher C.R. Allen[d], 
Thomas S. Moody[b/e], Brendan F. Gilmore*[a] 
 
Abstract: Chiral amines are valuable intermediates for the pharmaceutical industry, 
with up to 40% of current pharmaceuticals containing an amine functionality. 
However, their syntheses by conventional chemical methods often suffer from a 
number of key drawbacks. Transaminases (TAms) are pyridoxal phosphate (PLP) 
dependent enzymes capable of transferring an amine group to a prochiral ketone, 
offering a green and economically viable alternative to chiral amine production. 
Despite some high profile successes, TAms suffer from limited substrate scope and 
the ability to function under challenging conditions often required in reaction 
processes. Mining of untapped, extremophilic environments represents a viable 
approach in the search for novel enzymes. We report the cloning and expression of 
an (S)-selective ω-TAm from a Halomonas sp. (Ad2-TAm), isolated from an extreme 
hypersaline environment formed during the Triassic era (circa 220 mya). Ad2-TAm 
exhibits an ability to convert a range of structurally diverse aldehyde and ketone 
substrates, with no decrease in conversion up to 1.5 M (8.8%) NaCl. The enzyme is 
also tolerant to the presence of organic cosolvents up to 30% and accepts a range of 
amino donors. These characteristics make Ad2-TAm a promising candidate for 
industrial applications, whilst also highlighting the value of extreme environments as 
a source of novel enzymes for the pharmaceutical industry as a whole. 
Introduction 
Chiral amines are valuable and versatile building blocks for the pharmaceutical 
industry, with an estimated 40% of current pharmaceuticals containing an amine 
functionality.[1] Current chemical syntheses of chiral amines suffer from a number of 
drawbacks, including the need for toxic transition metal catalysts and volatile organic 
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solvents (VOCs), as well as insufficient stereoselectivity in a single step.[2] These 
drawbacks have, in part, driven the rise of biocatalysis for the production of optically 
active amines. Biocatalytic approaches initially involved hydrolases,[3] although 
other enzymes such as oxidases, lyases and transaminases (TAms) have been applied 
for this purpose,[4] as well as dehydrogenases which have been reviewed recently.[5] 
TAms are pyridoxal phosphate (PLP) dependent enzymes capable of 
transferring an amine group to a prochiral ketone, resulting in the formation of 
optically active amines. Despite high profile successes of TAm use in the 
pharmaceutical industry, namely the production of the antidiabetic drug sitagliptin,[6] 
there is a growing need for new enzymes with improved capabilities. The application 
of TAms is often hampered by a restricted substrate scope, lack of tolerance to harsh 
reaction conditions and an inability of enzymes to accept bulky substrates without 
considerable protein engineering.[6–8] 
Approaches to discover or create new TAms have involved both 
metagenomic approaches[9] and directed evolution of existing enzymes.[10,11] Another 
approach to overcome these challenges involves shifting the search for novel 
biocatalysts to previously untapped, extreme environments. The relatively 
understudied microbiomes of extreme environments represent a vast and exciting 
resource of novel organisms and biocatalysts. Extremophilic organisms are capable 
of functioning in conditions which render their mesophilic counterparts ineffective, 
such as high temperatures, extremes of pH and molar concentrations of salt. In this 
study we describe the isolation and characterisation of an ω-TAm from a Triassic salt 
mine in Kilroot, Northern Ireland. The protein, annotated as adenosylmethionine-8-
amino-7-oxononanoate aminotransferase (Ad2-TAm),[12] was identified, cloned and 
expressed from the genome of a bacterium from the genus Halomonas, given the 
designation CSM-2. CSM-2 was isolated from a thalassohaline environment formed 
over 200 million years ago and has remained relatively undisturbed ever since. This 
affords an opportunity to effectively take a step back along the evolutionary timeline 
and examine the microbes of the past. Such an insight could aid in the discovery of 
ancestral biocatalysts with potentially unique substrate ranges when compared to 
their modern cousins. 
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As well as tackling the issue of restricted substrate scope, biocatalysts from such 
an extreme hypersaline resource should prove capable of functioning under 
challenging reaction conditions often demanded by industrial processes. 
 
Experimental Section 
Organism isolation and identification 
 
Organism CSM-2 was isolated by inoculating media containing peptone (5 g/L), 
halite from Kilroot salt mine (10%) and agar (1.5%) with 100 μL undiluted brine 
collected from a brine stream in within the mine. Colonies were restreaked to ensure 
purity and colony PCR was carried out to amplify the 16S rRNA gene for 
identification, using 25 μL DreamTaq Green PCR Master Mix (2X) (Thermo Fisher 
Scientific, UK), 15 μL PCR-grade water and 5 μL each (2.5 μM) of universal primers 
27F (5'-AGAGTTTGATCMTGGCTCAG-3') and 1492R (5'-
TACGGYTACCTTGTTACGACTT-3'). PCR conditions were set up with the 
following parameters: initial denaturation at 94 °C for 3 min, 30 cycles of 
denaturation at 94 °C for 1 min, annealing at 55 °C for 1 min and extension at 72 °C 
for 1 min, followed by a final single extension step at 72 °C for 10 min. Agarose gel 
electrophoresis of PCR products (1% gel, 90 V, 45 min) was used to determine size 
and purity of PCR amplicons. These were subsequently cleaned using a GeneJet PCR 
Purification kit (Thermo Fisher Scientific, UK) as per manufacturer’s instructions 
and quantified using a Qubit® 2.0 Fluorometer (Invitrogen, UK). Concentration was 
adjusted to 10 μg/mL and sent for sequencing with Eurofins Genomics using the 27F 
primer. The BLASTn function associated with the NCBI database was used to 
compare the resulting sequence to known sequences for identification. 
 
 
DNA extraction and PCR amplification of Ad2-TAm gene 
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Genomic DNA was extracted from CSM-2 using GenElute™ Bacterial Genomic 
DNA Extraction kit (Sigma-Aldrich, UK) as per manufacturer’s instructions. A 
sample of extracted DNA was sent to MR DNA Lab (Shallowater, TX, USA) for 
whole genome sequencing (WGS) using the Illumina MiSeq platform and the 
remainder retained for PCR. The assembled genome was annotated by uploading to 
the RAST server, and the Ad2-TAm gene was identified using the SEED Viewer tool 
and search term ‘aminotransferase’. Forward (5’-
TTTTTTGAATTCATGACCTCGCCTGTCTGG-3’) and reverse (5’- 
TTTTTTCTCGAGCTAATGTTGCCCTGAGCTTTC-3’) primers were designed 
specific to the gene sequence (Invitrogen, UK) with restriction sites included for 
EcoRI and XhoI respectively (highlighted in bold). 2.5 μL (0.5 μM) of each primer 
along with 2 μL genomic DNA were added to 10 μL 5x Q5 reaction buffer, 1 μL (0.2 
mM) dNTPs, 0.5 μL Q5 High-Fidelity Polymerase, 10 μL 5x Q5 high GC enhancer, 
and nuclease-free water (to 50 μL) (all New England Biolabs Inc., MA, USA). PCR 
parameters were as follows: initial denaturation at 95 °C for 10 min, 35 cycles of 
denaturation at 95 °C for 30 s, annealing at 58 °C for 30 s and extension at 72 °C for 
1 min 30 s, followed by a final single extension step at 72 °C for 5 min. Amplicons 
were checked on a 1% agarose gel (90 V, 45 min) and bands of desired length were 
excised and DNA extracted using a QIAquick Gel Extraction kit (Qiagen, Hilden, 
Germany) as per manufacturer’s instructions. 
 
 
Preparation of pET28a+/Ad2-TAm vector 
 
25 μL pET28a+ vector and Ad2-TAm were each cut using restriction enzymes 
EcoRI-HF (1 μL) and XhoI (1 μL) (both New England Biolabs Inc., MA, USA) in a 
double digest with 3μL CutSmart buffer (NEB) for 1 h at 37 °C. 1 μL Alkaline Calf 
Intestinal Phosphatase (CIP) (NEB) was subsequently added to the pET28a+ mix and 
incubated for a further 1 h at 37 °C. Each sample was purified using a GeneJet PCR 
Purification kit (Thermo Fisher Scientific, UK) as per manufacturer’s instructions. 
Restricted pET28a+ (1 μL) and restricted Ad2-TAm gene (3 μL) were mixed with T4 
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DNA ligase buffer (1 μL) and T4 DNA ligase (1 μL) (both NEB), and adjusted to 10 
μL with ddH2O followed by overnight incubation at 16 °C. 
 
 
Transformation and expression of pET28a+/Ad2-TAm in Escherichia coli 
 
Following incubation, 2 μL of ligation mix was added to 20 μL One Shot® TOP10 
Chemically Competent Escherichia coli cells and gently pipetted to mix. This was 
incubated on ice for 30 min, heat shocked at 42 °C for 1 min before returning to ice 
for a further 2 min. SOC medium was added (200 μL; SOC = 0.5% yeast extract, 2% 
tryptone, 10 mM NaCl, 2.5 mM KCL, 10 mM MgCl2, 10 mM MgSO4, and 20 mM 
glucose per litre) and the mixture incubated at 37 °C with rotation for 1 h. The 
mixture was plated on nutrient agar containing 50 μg/mL kanamycin sulphate and 
incubated overnight at 37 °C. Cells were also transformed using the same method 
with empty pET28a+ vector for use as a negative control. Colony PCR using 5 μL 
RedTaq Polymerase (NEB), forward and reverse primers (0.5 μL of each), and 
ddH2O (to 10 μL) was carried out using the same gene-specific primers and PCR 
parameters as with the initial amplification. Amplicons were visualized on a 1% 
agarose gel (90 V, 45 min), sequenced by Eurofins Genomics, and aligned with the 
original gene sequence from WGS data using MEGA7 software. Individual colonies 
were picked and grown in 10 mL LB broth containing 50 μg/mL kanamycin sulphate 
overnight at 37 °C. Plasmids were extracted using a QIAprep spin Miniprep kit 
(Qiagen, Hilden, Germany) following manufacturer’s instructions. One Shot® BL21 
DE3 Chemically Competent E. coli cells (20 μL) were transformed with the 
recombinant plasmid (2 μL) using the same protocol as before. Individual colonies 
were picked as before and used to inoculate 10 mL LB broth with 50 μg/mL 
kanamycin sulphate, followed by incubation overnight at 37 °C with rotation. This 
primary culture was used to inoculate 1 L LB broth with 50 μg/mL kanamycin 
sulphate, which was allowed to grow to early log phase (OD ~0.6) at 37 °C with 
rotation. This was induced using IPTG to a final concentration of 0.4 mM and 
incubated at 20 °C overnight with rotation. Following incubation, the culture was 
pelleted via centrifugation, freeze-thawed at -80 °C, suspended in 0.1 M potassium 
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phosphate buffer (pH 8.0), and sonicated on ice. This was further centrifuged to 
remove cell debris. For use as a cell-free extract, the supernatant (lysate) was 
decanted and lyophilized overnight. Alternatively, the lysate was clarified using 0.8 
μM filters and purified as described below. 
 
 
His-tag-mediated purification of Ad2-TAm protein 
 
Clarified cell-free extract was purified by immobilized metal affinity 
chromatography (IMAC) using the N-terminal 6x His-tag encoded by the pET28a+ 
vector. An ÄKTA Prime Plus Liquid Chromatography System was used to load the 
clarate on a HisTrap™ HP 1 mL column (both GE Healthcare Life Sciences, UK) at 
a rate of 1 mL min-1. This was washed using buffer containing 50 mM NaH2PO4, 300 
mM NaCl, 20 mM imidazole, made up to 1 L with dH2O and adjusted to pH 8.0 with 
NaOH. Purified protein was eluted in 1 mL fractions using buffer containing 50 mM 
NaH2PO4, 300 mM NaCl, 250 mM imidazole made up to 1 L with dH2O and 
adjusted to pH 8.0 with NaOH. 
 
 
 
Expression and phylogenetic analysis 
 
Recombinant Ad2-TAm protein and empty vector controls were analysed via SDS-
PAGE using a NuPage® 4-12% Bis-Tris gel and NuPage® MES SDS running buffer, 
run at 200 V for 1 h. Recombinant Ad2-TAm was also analysed using Western Blot, 
with a gel set up as above and transferred to a nitrocellulose membrane at 30 V for 
2 h in buffer containing, per/L, tris 3.48 g, glycine 14.42 g, methanol 200 mL, made 
up to 1 L with dH2O. The resulting membrane was blocked using a solution of 5% 
skimmed milk in PBS at 37 °C (60 rpm) for 1 h, rinsed thoroughly in PBS, and 
treated with 1 in 10,000 monoclonal anti-polyhistidine-peroxidase antibody solution 
(Sigma-Aldrich, UK) at room temperature (60 rpm) for 1 h. After rinsing with PBS, 
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this was developed using a solution containing 12 mg 3,3’-diaminobenzidine, 10 μL 
30% H2O2, and 20 mL dH2O. 
 
 
Colorimetric screening assay using o-XDA as amino donor 
 
Using a protocol adapted from Green et al (2014)[1], o-XDA 1 (25 mM) and PLP (1 
mM in potassium phosphate buffer, 100 mM, pH 8.0) and the substrate (final 
concentration of 5 mM from an initial 50 mM stock in DMSO) were added to a 96-
well deep well plate to give a total volume of 180 μL. The reaction was started by the 
addition of either 20 μL rehydrated Ad2-TAm cell-free extract to a final working 
concentration of 20 mg/mL, or 20 μL purified protein at a final working 
concentration of 0.5 mg/mL. A colour change from yellow to black denoted a 
positive result for TAm-catalyzed conversion. 
 
 
HPLC-based screening assay employing (S)-MBA as amino donor 
 
(S)-MBA 2 (25 mM) and PLP (1 mM in potassium phosphate buffer, 100 mM, pH 
8.0), and the substrate (final concentration of 5 mM from an initial 50 mM stock in 
DMSO) were added to a 96-well deep well plate to give a total volume of 180 μL. 
For assays employing sodium pyruvate and α-ketoglutaric acid, stock concentrations 
of these substrates were prepared in water due to poor solubility in DMSO. These 
reaction mixes were then supplemented with an appropriate amount of DMSO. The 
reaction was initiated by the addition of 20 μL rehydrated Ad2-TAm cell-free extract 
to a final working concentration of 20 mg/mL. Purified Ad2-TAm was also tested for 
ability to convert substrates using 20 μL purified protein at a final working 
concentration of 0.5 mg/mL. After incubation for 16 h at 30 °C and 1200 rpm, the 
reaction was quenched with 800 μL 62.5% acetonitrile and denatured protein was 
removed by centrifugation. 200 μL of supernatant was removed for analysis by 
HPLC using a Kinetex 5u C18 100A column (50 x 4.6 mm) and an Agilent 1260 
Infinity model, with detection of acetophenone 4 coproduct at 240 nm. Product 
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formation in the assays employing purified protein was also detected using a diode 
array detector (DAD) at 10 nm intervals from wavelengths 210 nm to 270 nm. The 
concentration of acetophenone coproduct formation was determined over 8 min 
using a gradient of 5-50% organic solvent (where A = dH2O with 0.1% H3PO4 and B 
= acetonitrile with 0.1% H3PO4). Acetophenone eluted at a retention time of 5.9 min. 
Assays using both Ad2-TAm and vector only controls were carried out in triplicate 
for each substrate, with an average taken for each and values for negative control 
subtracted from Ad2-TAm values. 
 
 
HPLC-based screening assay employing cinnamaldehyde as substrate 
 
Amino donor (25 mM) and PLP (1 mM in potassium phosphate buffer, 100 mM, pH 
8.0) and cinnamaldehyde 9 (final concentration of 5 mM from an initial 50 mM stock 
in DMSO) were added to a 96-well deep well plate to give a total volume of 180 μL. 
The reaction was started by the addition of 20 μL rehydrated Ad2-TAm cell-free 
extract to a final working concentration of 20 mg/mL. After incubation for 16 h at 
30 °C and 1200 rpm, the reaction was quenched with 800 μL 62.5% acetonitrile and 
denatured protein was removed by centrifugation. 200 μL of supernatant was 
removed for analysis by HPLC using a Kinetex 5u C18 100A column (50 x 4.6 mm) 
with detection at 210 nm. The concentration of cinnamyl amine 20 product formation 
was determined over 8 min using a gradient of 5-50% organic solvent (where A = 
dH2O with 0.1% H3PO4 and B = acetonitrile with 0.1% H3PO4). Cinnamyl amine 
eluted at a retention time of 2.8 min. Assays using both Ad2-TAm and vector only 
controls were carried out in triplicate for each amino donor, with an average taken 
for each and values for negative control subtracted from Ad2-TAm values. 
 
 
Evaluation of enzyme performance under varying reaction parameters 
 
(S)-MBA 2 (25 mM) and PLP (1 mM in potassium phosphate buffer, 100 mM, pH 
8.0 unless changed to assess effect of changing pH), and benzaldehyde (final 
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concentration of 5 mM from an initial 50 mM stock in DMSO) were added to a 96-
well deep well plate to give a total volume of 180 μL. The reaction was initiated by 
the addition of 20 μL rehydrated Ad2-TAm cell-free extract to a final working 
concentration of 20 mg/mL. After incubation for 16 h at 30 °C (unless changed to 
assess effect of changing temperature) and 1200 rpm, the reaction was quenched with 
800 μL 62.5% acetonitrile and denatured protein was removed by centrifugation. 200 
μL of supernatant was removed for analysis by HPLC using a Kinetex 5u C18 100A 
column (50 x 4.6 mm) and an Agilent 1260 Infinity model, with detection of 
acetophenone 4 coproduct at 240 nm. The concentration of acetophenone coproduct 
formation was determined over 8 min using a gradient of 5-50% organic solvent 
(where A = dH2O with 0.1% H3PO4 and B = acetonitrile with 0.1% H3PO4). 
Acetophenone eluted at a retention time of 5.9 min. Assays using both Ad2-TAm and 
vector only controls were carried out in triplicate for each substrate, with an average 
taken for each and values for negative control subtracted from Ad2-TAm values. 
To assess the effect of temperature on enzyme performance, assays were set up 
as described above but incubated at different temperatures, ranging from 20-45 °C. 
To assess the effect of changing pH on enzyme performance, assays were set up 
using a universal buffer[2] in place of phosphate buffer. This contained 25 mM citric 
acid, 25 mM KH2PO4, 25 mM Tris, 12.5 mM Na2B4O7 and 25 mM KCl, adjusted 
using NaOH, with pH values from pH 6.0 to 11.0 investigated. 
To assess the effect of organic solvents on enzyme performance, more 
concentrated stock solutions of potassium phosphate buffer (pH 8.0) were prepared 
to reduce the aqueous volume in the reaction accordingly, with PLP concentrations 
also adjusted in buffer solutions accordingly. Once diluted by the required amount of 
organic solvent, the overall concentrations of potassium phosphate buffer (pH 8.0) 
and PLP in solution remained at 100 mM and 1 mM, as before. Concentrations of 
organic solvents investigated ranged from 0-30%. 
To assess the effect of increasing salt concentration on enzyme performance, 
potassium phosphate buffer stock solutions were prepared containing the required 
amounts of NaCl and KCl respectively (warmed gently where necessary to dissolve 
fully). These were prepared so that the dilutive effect of other reaction constituents 
ensured the appropriate overall salt concentration in the assay. Buffer pH was 
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adjusted using small amounts of NaOH to account for the addition of salt. Salt 
concentrations assessed ranged from 0-2.5 M for both NaCl and KCl. 
In assessing the effect of increased volume of reaction, (S)-MBA 2 (25 mM) and 
PLP (1 mM in potassium phosphate buffer, 100 mM, pH 8.0) and benzaldehyde 3 
(final concentration of 5 mM from an initial 50 mM stock in DMSO) were added to a 
sterile 250 mL conical flask to give a total volume of 90 mL. The reaction was 
started by the addition of 10 mL rehydrated Ad2-TAm cell-free extract to a final 
working concentration of 20 mg/mL. After incubation for 16 h at 30 °C and 100 rpm, 
the reaction mixture was transferred to a sterile 1 L flask and the reaction quenched 
with 400 mL 62.5% acetonitrile. Denatured protein was removed by centrifugation. 
200 μL of supernatant was removed for analysis by HPLC using a Kinetex 5u C18 
100A column (50 x 4.6 mm) with detection at 240 nm. The concentration of 
acetophenone product formation was determined over 8 min using a gradient of 0-
50% organic solvent (where A = dH2O with 0.1% H3PO4 and B = acetonitrile with 
0.1% H3PO4) with subtraction of empty vector negative control. The acetophenone 
product eluted at a retention time of 5.9 min. 
 
 
Determination of specific activity 
 
(S)-MBA 2 (25 mM) and PLP (1 mM in universal buffer (as above) pH 9.0), and 
benzaldehyde 3 (final concentration of 5 mM from an initial 50 mM stock in DMSO) 
were added to a 1.5 mL microtube to give a total volume of 180 μL. The reaction 
was initiated by the addition of 20 μL rehydrated Ad2-TAm cell-free extract to a 
final working concentration of 1 mg/mL. Reactions were quenched with 800 μL 
62.5% acetonitrile at regular time intervals and denatured protein was removed by 
centrifugation. 200 μL of supernatant was removed for analysis by HPLC using an 
XBridge® C18 3.5 μm column (100 x 4.6 mm) and an Agilent 1260 Infinity model, 
with detection of acetophenone 4 coproduct at 240 nm. The concentration of 
acetophenone coproduct formation was determined over 10 min using a gradient of 
5-50% organic solvent (where A = dH2O with 0.1% H3PO4 and B = acetonitrile with 
0.1% H3PO4). Acetophenone eluted at a retention time of 9.0 min. Assays using both 
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Ad2-TAm and vector only controls were carried out in triplicate, with an average 
taken for each and values for negative control subtracted from Ad2-TAm values. 
Ad2-TAm concentration in cell-free extract was determined using a combination of a 
Qubit® 2.0 Fluorometer (Invitrogen, UK) and SDS-PAGE densitometry. 
  
FULL PAPER   
 
 
 
 
 
 
Results and Discussion 
Organism identification and gene selection 
 
The organism, from which the TAm enzyme was cloned and expressed, was isolated 
from a brine sample from Kilroot salt mine and given the designation CSM-2 (This 
Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank under 
the accession NBYR00000000. The version described in this paper is version 
NBYR01000000). Using the Basic Local Alignment Search Tool nucleotide 
(BLASTn) function[13] of the National Center for Biotechnology Information (NCBI) 
database,[14] the organism was found to be a member of the genus Halomonas, with 
the closest neighbour deemed to be Halomonas janggokensis M24 (99% similarity). 
 On uploading the assembled contigs from WGS data to the Rapid Annotations 
using Subsystems Technology (RAST) server,[12] the subsystems search tool revealed 
29 results using the search term ‘aminotransferase’. The gene ‘adenosylmethionine-
8-amino-7-oxononanoate aminotransferase’ was selected based on PLP fold type 
(Fold type I) and TAm class (Class III) known to be industrially relevant.[15] The 
gene was 1284 bp in length and the corresponding protein was given the designation 
Ad2-TAm. 
 
 
Fig. 1. SDS-PAGE a) and Western Blot b) of pre-purified clarate (well 2) and Ad2-TAm fractions, purified by His-tagged protein 
purification (wells 3-7), alongside SeeBlue® Plus2 Protein Standard (well 1). 
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Purification and expression analysis 
 
SDS-PAGE analysis following purification showed the formation of a 47 kDa 
protein (Fig. 1A.), commensurate with a gene length of 1284 bp. Analysis using 
Western Blotting further confirmed the presence of the desired protein, using the 6x 
His-tag encoded by the pET28a+ vector in combination with an N-terminal anti-
polyhistidine-peroxidase antibody (Fig. 1B.). 
 
 
Phylogenetic analysis and alignment with other TAms 
 
 A number of other TAms were cloned and expressed from bacterial isolates 
using the same approach as with Ad2-TAm (Supplementary Fig. 1). These proteins 
were not expressed in soluble form and therefore did not possess any biocatalytic 
activity. Attempts to solubilise these proteins with urea followed by refolding in salt-
containing buffer were unsuccessful. Varying expression conditions by reducing 
temperature and changing IPTG concentration was 
also tried without success. The amino acid sequences 
for these genes, relative to that of Ad2-TAm, are 
shown in Fig. 2, as well as a number of sequences 
from TAms of known organisms: Vibrio fluvialis 
(Vf-TAm),[16] Pseudomonas putida (Pp-TAm),[17] 
Chromobacterium violaceum (Cv-TAm)[18] and 
Halomonas sp. (Hs-TAm).[19] A neighbour-joining 
tree was generated using MEGA 7,[20] with bootstrap 
values calculated based on 1000 replicates. Using 
protein BLAST (BLASTp) function[13] associated 
with the NCBI database, the closest neighbour to 
Ad2-TAm was determined to be a TAm from 
Halomonas sp., with a sequence similarity of 89%. 
Ad2-TAm shared relatively low homology with 
Fig. 2. Amino acid sequences of TAm genes from whole 
genomes (including Ad2-TAm - highlighted in yellow) and a 
number of TAms from identified species (Pp-TAm, Cv-TAm, 
Vf-TAm and Hs-TAm - shown in red) were used to create a 
neighbour-joining tree (bootstrap values calculated from 1000 
replicates). 
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commonly employed TAms (Vf-TAm - 28%, Pp-TAm - 28%, Cv-TAm - 30%). 
Despite the low level of homology, many critical residues were conserved across all 
sequences (Fig. 3). These include a tryptophan residue at position 60 (W60), which 
is key for substrate specificity; a tyrosine residue at position 153 (Y153), which 
allows for hydrogen bonding of a hydroxyl group to the phosphate group of PLP; and 
a lysine residue at position 288 (K288), critical for Schiff base formation.[21] 
 
 
Screening purified Ad2-TAm for ability to convert substrates 
 
Purified Ad2-TAm was tested for the ability to convert substrates using a selection of 
compounds (shown with an asterisk in Fig. 4) and o-xylylenediamine (o-XDA) 1 as 
amino donor (Scheme 1A). Aldehydes, aromatic ketones, and a ketose were accepted 
by the purified enzyme, demonstrating the versatility of Ad2-TAm’s substrate range 
(Fig. 5). In each case, the same imidazole-containing buffer used to elute Ad2-TAm 
from the purification column was used as a negative control (full triplicate results 
shown in Supplementary Fig. 2). 
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 (S)-methylbenzylamine ((S)-MBA) 2 was 
also used as an amino donor in a HPLC-based assay 
(Scheme 1B.), employing benzaldehyde 3 as 
substrate. The resultant HPLC separation was 
observed over a range of wavelengths, with the more 
hydrophilic amino donor eluted early in the run with 
a retention time (RT) of 1.5 min, and the more 
hydrophobic acetophenone product (RT 5.9 min) and 
remaining benzaldehyde substrate (RT 5.1 min). This 
reaction proceeded with a 26% conversion.  
 
 
Screening Ad2-TAm cell-free extract for ability to convert substrates 
 
Pp-TAm  NMPEHAGASLASQLKLDAHWMPYTANRNFLR-DPRLIVAAEGSWLVDDKGRKVYDSLSGLWTCGAGHTRKEIQEAVAKQLSTLD-YSPGFQYGHPLSFQ
Cv-TAm  MQKQR-TTSQWRELDAAHHLHPFTDTASLNQAGARVMTRGEGVYLWDSEGNKIIDGMAGLWCVNVGYGRKDFAEAARRQMEELPFYNTFFKTTHPAVVE
Vf-TAm  MNKPQ----SWEARAETYSLYGFTDMPSLHQRGTVVVTHGEGPYIVDVNGRRYLDANSGLWNMVAGFDHKGLIDAAKAQYERFPGYHAFFGRMSDQTVM
Hs-TAm  MTTP--------------VWHPYAHLKT--QTPAPKVVGGDGAHFVLESGERLLDATCSWWCMIHGYGHPRLVAAIREQAGKLC-HVMLGGLTHDPADQ
Ad2-TAm MTSP--------------VWHPYADLKH--QSPAPKVVGGDGAHFVLESGERLLDATCSWWCMIHGYGHPRLVAAIREQAGELC-HVMLGGLTHEPADR
 
Pp-TAm  AEKITDLTPGNLNHVFFTDSGSECALTAVKMVRAYWRLKGQATKTKMIGRARGYHGVNIAGTSLGG-VNGNRKLFGQPMQDVDHLPHTLLASNAYSR-
Cv-TAm  SSLLAEVTPAGFDRVFYTNSGSESVDTMIRMVRRYWDVQGKPEKKTLIGRWNGYHGSTIGGASLGG-MKYMHEQGDLPIPGMAHIEQPWWYKHG-KD-
Vf-TAm  SEKLVEVSPFDSGRVFYTNSGSEANDTMVKMLWFLHAAEGKPQKRKILTRWNAYHGVTAVSASMTG-KPY-NSVFGLPLPGFVHLTCPHYWRYG-EEGE
Hs-TAm  ARELVRITPAGLNHVFYSDSGSVGMEVAMKMALQYQVLAGNPGKQKMLSLMKAYHGDTTGCMAVCDPEEGMHSLFASLLPQHHFAPAPTA---P-FD-
Ad2-TAm ARELVRITPTGLDHVFYSDSGSVGMEVAMKMALQYQVLTGNPGKRRMLSLMKAYHGDTTGCMAVCDPEEGMHGLFTGLLPRHYFAPAPTA---P-YD-
 
Pp-TAm  PKEGGIALADELLKLIELHDASNIAAVFVEPLA-GSAGVLVPPEGYLKRNREICNQHNILLVFDEVITGFGRTGSMFGADSFGVTPDLMCIAKQVTNG
Cv-TAm  PDEFGVVAARWLEEKILEIGADKVAAFVGEPIQ-GAGGVIVPPATYWPEIERICRKYDVLLVADEVICGFGRTGEWFGHQHFGFQPDLFTAAKGLSSGYL
Vf-TAm  EEQFVARLARELEETIQREGADTIAGFFAEPVM-GAGGVIPPAKGYFQAILPILRKYDIPVISDEVICGFGRTGNTWGCVTYDFTPDAIISSKNLTAG
Hs-TAm  AEQVEQDL-SALRDVL-ERHHEEIAALLMEPLLQAAGGLNMTSPAYVAGARALCDEFGVLLIFDEVATGFGRTGKLFAADHASVTPDIMVLSKGLTGGYL
Ad2-TAm PEQVEHDL-SALREVL-ERHHDEIAALLMEPLLQAAGGLNMTSPDYLRGARALCDEFGVLLIFDEVATGFGRTGKLFAADHADITPDIMVLSKGLTGGYL
 
Pp-TAm  PMGAVIASTEIYQTF----MNQPTPEYAVEFPHGYTYSAHPVACAAGLAALCLLQKENLVQSVA-EVAPHFEKALHG---IKGAKNVIDIRNFGLAGAI
Cv-TAm  PIGAVFVGKRVAEGL----IA------GGDFNHGFTYSGHPVCAAVAHANVAALRDEGIVQRVKDDIGPYMQKRWRE--TFSRFEHVDDVRGVGMVQA
Vf-TAm  PMGAVILGPELSKRLETAIEA------IEEFPHGFTASGHPVGCAIALKAIDVVMNEGLAENVR-RLAPRFEERLKH---IAERPNIGEYRGIGFMWA
Hs-TAm  GHAATLATDRVHNAF----IGD-SP--QHAFMHGPTFMGNPLACRVALESLQVFEDENYLGKIA-TLSQQLQRELLEDQALNAHSAVADVRVLGATAV
Ad2-TAm GHAATLATNRVHDAF----IGD-SE--HHAFMHGPTFMGNPLACRVALESLRVFEEEDYLGKIA-TLNQLLRHELLEDPALNAHPAVADVRVLGATAV
 
Pp-TAm  IAPRDGDAIVRPF------EAGMAL----WKAGFYVRFGGDTLQFGPTFNSKPQDLDRLFDAVGEVLNKLL--------D 
Cv-TAm  LVKNKAKRELFPDF----GEIGTLCRDIFFRNNLIMRACGDHIVSAPPLVMTRAEVDEMLAVAERCLEEFEQTLKARGLA 
Vf-TAm  AVKDKASKTPFDGNLSVSERIANTC----TDLGLICRPLGQSVVLCPPFILTEAQMDEMFDKLEKALDKVFAEV-----A 
Hs-TAm  AHSAEALKG-----------VGNFA----RERGVWLRPIGRWLYTMPAYITSEAEITQITDVMKAWFLRP---E------ 
Ad2-TAm AHSAEALKG-----------VAGFA----RERGVWLRPIGRWLYTMPAYITSETEMVQVTDVMKAWFLESSGQH------ 
 
Fig. 3. Multiple alignment of amino acid sequence of Ad2-TAm with a number of TAms from identified species (Pp-TAm, Cv-TAm, Vf
TAm and Hs-TAm). Key residues for activity and substrate specificity are conserved across all sequences, including Trp60, Tyr153 and 
Lys288 (highlighted in red). 
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Purification of the His-tagged protein allowed for characterisation and basic testing 
of the pure, expressed enzyme’s ability to convert substrates. However, lack of 
stability associated with the purified protein led to difficulties in scale-up and 
increasing the enzyme concentration in the reaction. A number of approaches 
including lyophilisation and dialysis were attempted in order to overcome this issue, 
but led to precipitation of the protein on dialysis or resuspension. With the use of 
empty vector (pET28a+) controls, the cell-free extract was deemed to represent a 
more suitable approach to characterising the ability of Ad2-TAm to convert different 
substrates. It was possible to lyophilize and resuspend Ad2-TAm as a cell-free 
extract, allowing for greater enzyme loading in assays. This provided a more 
accurate reflection of the capabilities of Ad2-TAm as a biocatalyst. 
 
 
 
Colorimetric assay using o-XDA as amino donor 
 
The colorimetric assay (Scheme 1A.) once again demonstrated the versatility of 
Ad2-TAm as a biocatalyst, with the enzyme able to accept a diverse range of 
substrates. As observed in Fig. 7, both aromatic and aliphatic aldehydes and ketones 
were aminated, whilst no colour change was observed with the vector only control in 
each case (Supplementary Fig. 3). This broad substrate acceptance is typical of 
Class III TAm enzymes,[9,22–24] and represents one of the key advantages of using this 
particular group for chiral amine synthesis. 
 This assay is useful as an initial visual screen for active TAms, but is limited by 
its high level of sensitivity, often producing positive results when no substrate is 
added to the reaction mixture, with PLP acting as amino acceptor. Despite this, there 
appears to be a broad correlation between the intensity of the black colour formed at 
30 min (Fig. 7) and those substrates which were best 
converted at 16 h, as shown by the HPLC-based 
screening assay (Table 1.). It is worth noting other 
colorimetric assays which have been developed 
recently for high-throughput screening of TAms may 
Fig. 4 – Substrates screened with assay A (using (S)-MBA 
as an amino donor and HPLC detection of acetophenone at 
240 nm) and C (using o-XDA as an amino donor and 
observing formation of coloured precipitate to denote TAm
catalyzed substrate conversion). Those substrates used in 
testing of IMAC-purified Ad2-TAm are shown with an 
asterisk. 
  
FULL PAPER   
 
 
 
 
 
circumvent such issues.[25] 
 
 
HPLC-based screening assay using (S)-MBA as amino donor 
 
The same substrates used in the colorimetric assay were tested using a HPLC-based 
assay with (S)-MBA 2 as amino donor (Scheme 1B.). Assays were carried out in 
triplicate, with results for vector only controls subtracted in each case. Acetophenone 
4 product formation, detected a 240 nm, was used to determine conversion (%) for 
each substrate. Ad2-TAm performed well with many aldehyde substrates, with good 
conversion of both aliphatic and aromatic aldehydes (benzaldehyde 3 55%, 
acetaldehyde 5 52%). Increases in substrate acyl chain length led to a reduction in 
conversion (octanal 6 22% vs. butyraldehyde 7 49%), consistent with observations 
noted in the limited existing literature.[9] Similar results were observed with the 
addition of side groups to the benzyl ring of aromatic aldehydes  (benzaldehyde 55% 
vs. 4-hydroxybenzaldehyde 8 and cinnamaldehyde 9, 39% and 36% respectively). 
Aromatic ketones followed a similar pattern, with simpler structures showing higher 
levels of amination than their more complex 
counterparts (cyclohexanone 10 49% vs. 2-
hydroxyacetophenone 11 39%, 4-bromoacetophenone 
12 12% and propiophenone 13 4%). Bicyclic ketones 
such as the steroid building block 1-indanone 14 (7% 
conversion) and the biphenyl ketone benzophenone 
15 (2% conversion) were poorly accepted by Ad2-
TAm, most likely due to the steric constraint afforded 
by their bulky substituents. Aliphatic ketones showed 
poor conversion yields, (sodium pyruvate 16 4%, 2-heptanone 17 7%, α-ketoglutaric 
acid 18 6%), whilst Ad2-TAm displayed a reasonable ability to convert the ketose 
sugar L-erythrulose 19 (25% conversion). It is notable that Ad2-TAm exhibited 
greater conversion of aldehydes than ketone substrates, which can be attributed to the 
greater reactivity of aldehydes given the greater electrophilicity of their carbonyl 
Scheme 1. A. o-XDA screening assay performed against 
multiple substrates. Reaction conditions: o-XDA 25 mM, 
substrate 5 mM, PLP 1 mM, potassium phosphate buffer, 
pH 8.0, 100 mM, enzyme as cell-free extract (20 mg/mL) or 
His-tagged purified protein (0.5 mg/mL), 16 h, 30 °C, 
1200 rpm. B. (S)-MBA screening assay performed against 
multiple substrates. Reaction conditions: (S)-MBA 25 mM, 
substrate 5 mM, PLP 1 mM, potassium phosphate buffer, pH 
8.0, 100 mM, enzyme as cell-free extract (20 mg/mL) or His
tagged purified protein (0.5 mg/mL), 16 h, 30 °C, 1200 rpm. 
C. Cinnamaldehyde screening assay performed using 
multiple amino donors. Reaction conditions: amino donor 
25 mM, cinnamaldehyde 5 mM, PLP 1 mM, potassium 
phosphate buffer, pH 8.0, 100 mM, enzyme as cell-free 
extract (20 mg/mL) or His-tagged purified protein 
(0.5 mg/mL), 16 h, 30 °C, 1200 rpm. 
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group vs. ketones.[22] Percentage 
conversion for all substrates tested 
are shown in Table 1. When no 
substrate was used in the reaction 
conversion values were <1%. 
 Specific activity was 
determined as 0.11 U/mg for 3. 
One unit is defined as the amount 
of enzyme that produces 1 μmol of 
acetophenone in 1 min. Although 
benzaldehyde may not be the 
cognate substrate for Ad2-TAm in 
nature, the relatively low value obtained highlights the potential need for directed 
evolution to improve specific activity of this enzyme towards certain substrates. Such 
site-specific mutations have proven extremely successful in improving the activity of 
TAms by several orders of magnitude, with a growing number of examples in the 
current literature.[6,8,11] 
 
 
PLC-based screening assay using cinnamaldehyde as substrate  
 
The ability of Ad2-TAm to utilize a range of amino donors was examined with a 
HPLC-based assay using cinnamaldehyde 9 as substrate in each case (Scheme 1C). 
Assays for each amino 
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donor were carried out in triplicate, with values for vector only controls subtracted 
from Ad2-TAm to provide overall values. Formation of cinnamyl amine 20 product 
(detected at 210 nm) was used to determine relative ability of the enzyme to accept 
each amino donor. Of the compounds tested, o-XDA 1 proved to be the most 
effective amino donor (Fig. 8A.). As well as being readily accepted by the enzyme, 
o-XDA also benefits from a 
favourable reaction equilibrium. 
The imine product of the initial 
deamination of o-XDA 
undergoes spontaneous 
tautomerization to form an 
aromatic isoindole. This 
effectively removes one of the 
products from the reaction mixture, 
allowing the equilibrium of the 
reaction to shift towards further 
product formation.[26] Recently 
this work has been developed 
further with the advent of ‘smart’ diamine donors, whose corresponding 
aminoaldehydes can dimerize or cyclize following transamination.[7] This has been 
shown to substantially reduce product inhibition, which can present significant 
problems for TAm-catalyzed reactions and have a negative impact on conversion 
yield.[27–29] 
 Varying the amino donor also reveals the enantiopreference of Ad2-TAm. The 
relative ability of Ad2-TAm to accept (S)-MBA 2 (vs. o-XDA at 100%) as an amino 
donor was 89%. Comparing this value with its ability to accept the (R)-enantiomer of 
MBA 21 (17%) and a racemic mixture 22 of the two isomers (52%), clearly shows 
Ad2-TAm to be an (S)-selective enzyme (Fig. 8A.). 
Fig. 8A. shows the smaller amino donors isopropylamine 23 (IPAm) and L-
alanine 24 to be less readily accepted by Ad2-TAm as amino donors, although some 
conversion was still observed. 
 
Fig. 5. Colorimetric assay employing a selection of substrates (5 mM) (A. 
3, B. 7, C. 19, D. 9, E. 10). o-XDA (25 mM) was used as amino donor with 
all assays set up in potassium phosphate buffer, pH 8.0 (100 mM), 
containing PLP (1 mM). Reaction was started by addition of His-tagged 
purified Ad2-TAm to a final concentration of 0.5 mg/mL (wells in column 
2) and allowed to proceed for 16 h at 30 °C and 1200 rpm. Elution buffer 
(50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0) was used 
as a negative control (wells in column 1).  
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Characterisation of the catalytic ability of Ad2-TAm using different reaction 
parameters 
 
Using a HPLC-based screening assay with (S)-MBA as amino donor and 
benzaldehyde as amino acceptor, the catalytic ability of Ad2-TAm was determined 
over a range of temperatures and pH (Fig. 8B. and C respectively). As expected with 
a halotolerant bacterial enzyme, Ad2-TAm displayed a largely mesophilic profile in 
terms of a temperature optimum of 30 °C, as has been observed with other bacterial 
TAms.[9] Despite optimum conversion at pH 9.0, Ad2-TAm continued to bring about 
a relatively high level of conversion from pH 8.0 to 11.0. This is consistent with 
limited published data on TAms from halotolerant bacteria.[22] Many halotolerant 
organisms are also alkalotolerant, owing to the environments in which they are often 
found. High-salt environments are often alkaline in nature, such as soda lakes, 
resulting in the emergence of haloalkalotolerant microorganisms. 
Ad2-TAm showed an ability to convert substrate in organic solvents, with 67% 
conversion in 10% dimethylformamide (DMF). Previous use of DMF as a solvent 
has been applied to TAm-
catalyzed reactions in the 
production of pharmaceuticals. Its 
addition as a co-solvent improved 
both the reaction process and 
substrate loading in the 
production of an intermediate for 
the pro-drug silodosin, used in the 
treatment of benign prostatic 
hypertrophy.[31] With Ad2-TAm, 
an increase above 10% 
concentration of DMF led to a 
dramatic reduction in 
conversion. However, increasing 
Fig. 6. Amino donors screened with assay B (using cinnamaldehyde as 
amino acceptor and HPLC detection of cinnamyl amine at 210 nm). 
Fig. 7. Colorimetric assay employing a number of substrates (5 mM) (A1. 
3, B1. 5, C1. 19, D1. 17, E1. 7, F1. 6, G1. 9, H1. 10, A2. 13, B2. 12, C2. 
14, D2. 15, E2. 18, F2. 16, G2. 11, H2. 8). o-XDA (25 mM) was used as 
amino donor with all assays set up in potassium phosphate buffer, pH 8.0 
(100 mM), containing PLP (1 mM). Reaction was started by addition of 
Ad2-TAm cell-free extract to a final concentration of 20 mg/mL and 
allowed to proceed for 30 min at 30 °C and 1200 rpm. DMSO in place of 
substrate was used as a control (well A3). Empty pET28a+ vector cloned 
into E. coli BL21 DE3 cells was used as an additional control with no 
substrate (well B3). 
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the concentration of dimethyl sulphoxide (DMSO) from 10% to 20% led to an 
increase in conversion from 51% to 68%.[30] 
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 Subsequent decrease in conversion was only seen when DMSO was increased to 
30%, although the enzyme continued to function well at this concentration. As many 
substrates for TAm-catalyzed reactions are poorly soluble,[6] a greater amount of 
substrate in solution may account for the increase in conversion at 20% DMSO. 
Nonetheless, substrate solubility can be an important limiting factor in TAm-
catalyzed reactions,[6] and an enzyme capable of functioning at high concentrations 
of organic solvent could prove very valuable in chiral amine synthesis. 
Ad2-TAm showed reasonable tolerance to a number of other organic solvents, 
showing >10% conversion rates in methanol, ethanol and isopropanol (Fig. 8D.). 
Conversion quickly deteriorated upon increases in concentration of these solvents 
above 10%. When no co-solvent was used in the reaction, an average conversion of 
only 14% was achieved.  
Table 1. Overall conversion for a number of substrates under the following reaction conditions: (S)-MBA (25 mM), substrate (5 mM), PLP 
(1 mM), potassium phosphate buffer, pH 8.0 (100 mM). Reaction was started by addition of Ad2-TAm cell-free extract to a final 
concentration of 20 mg/mL and allowed to proceed for 16 h at 30 °C and 1200 rpm. Empty pET28a+ vector cloned into E. coli BL21 DE3 
cells was used as a negative control. All experiments were carried out in triplicate with empty vector control readings subtracted from cell
free extract readings. Conversions were obtained via detection of acetophenone formation at 240 nm and varied by <±2%, with the 
exception of acetaldehyde (<±8%). 
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The effect of varying salt concentrations on conversion was also examined, with 
Ad2-TAm displaying a high level of tolerance to both NaCl and KCl (Fig. 8E.). 
Acetophenone was formed with 54% conversion at 1.5M NaCl. Maximum 
Fig. 8A. The effect of different amino donors on the amination of cinnamaldehyde, shown as relative substrate conversion based on the 
detection of cinnamyl amine formation at 210 nm. B-E. The effect of various parameters on the amination of benzaldehyde using Ad2-
TAm cell-free extract, using (S)-MBA as amino donor with acetophenone formation measured at 240 nm. Plotted values are the mean of 
triplicate measurements, with error bars representing ± standard deviation in each case. 
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conversion with KCl was seen at 0.5 M, with 55% conversion, with >85% of this 
conversion still achieved at 1.5 M KCl. 
Halotolerance of Ad2-TAm was assessed against the commercially available ω-
TAm from Penicillium chrysogenum (Pc-TAm), a mesophile (Fig. 8E.). Ad2-Tam 
displayed much greater tolerance to increasing concentrations of salt than Pc-TAm, 
with maximum conversion observed at 1.5 M NaCl vs. only 66% relative conversion 
for Pc-TAm at this salinity (Fig. 8E.). As NaCl concentration was increased further, 
Ad2-TAm continued to produce significantly greater conversions than the fungal 
enzyme. These observations are all the more impressive in view of the osmotic 
tolerance exhibited by fungi[32–36] such as P. chrysogenum. Moderately halophilic 
bacteria are adapted to high salt environments via a process known as ‘salting out’. 
Efflux pumps remove NaCl from within the cell, which is replaced by compatible 
solutes such as zwitterions or sugars in order to maintain the osmotic balance with 
outside the cell.[37–39] As such, their intracellular machinery does not possess the 
specific adaptations to high salinities exhibited by their haloarchaeal counterparts. 
These observations demonstrate the Ad2-TAm enzyme to be at the very least 
moderately halotolerant. The ability of this enzyme to function at increased salinity 
represents a promising addition to a currently scarce list of successes of TAms from 
halotolerant organisms. 
Using (S)-MBA 2 as amino donor and benzaldehyde 3 as substrate, the 
original 200 μL reaction volume was increased to 100 mL, representing a 500× 
increase in total reaction volume. A decrease from 55% to 30% conversion was 
observed on volume increase, suggesting further improvements would be needed to 
the process in order to apply Ad2-TAm as a biocatalyst on an industrial scale. Future 
work for upscale is ongoing, with details of product recovery, isolation and optical 
purity required before the suitability of Ad2-TAm can be fully assessed as a 
candidate for industrial applications. Increasing substrate loading beyond the 5 mM 
concentration used in this investigation is also a factor for further investigation. 
Despite these areas which require further work, the conversion seen in organic 
solvents, at high salt, and over a range of pH values, suggests Ad2-TAm has 
potential as a candidate for application in industrial processes. 
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Conclusions 
Limited substrate scope of current TAms and their inability to tolerate challenging 
reaction conditions has driven the search for new enzymes. We have reported the 
cloning and expression of a novel biocatalyst from an extreme hypersaline 
environment, formed over 220 million years ago. Enzyme Ad2-TAm possessed a 
broad substrate range and an ability to function under challenging parameters. As 
well as accepting both aliphatic and aromatic ketones and aldehydes, Ad2-TAm also 
demonstrated an ability to convert substrate over a range of pH values, as well as in 
organic solvent and at elevated salinities. These characteristics highlight the potential 
benefits of employing enzymes from halotolerant organisms in biocatalysis, 
including a capacity to aminate substrates under conditions which are often too 
challenging for mesophilic enzymes. These observations also highlight Ad2-TAm as 
a potential biocatalyst for chiral amine synthesis in the pharmaceutical industry. 
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